H. France, F. G. Paris, G. Pascale, and . Pascale, 7 Cancer Diagnosis Program, National Cancer Institute, 3 Centre de Recherche des Cordeliers. 6 Infectious Disease and Immunogenetics Section (IDIS), Clinical Center and trans-NIH Center for Human Immunology (CHI), pp.14-15

/. Institute, . Centre, . Toronto, and C. On, 28 Division of Cellular Signaling 29 Department of Digestive Surgery and Surgical Oncology, Graduate School of Medicine, pp.32-33

. Montréal, 39 Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, p.44

T. Gujarat-cancer, &. Research-institute, . Asarwa, and I. Ahmedabad, The Netherlands. 47 Institute for Cancer Research, Center of Translational medicine, Xi'an Jiaotong university, Xian, China. 48 Department of Histopathology 50 Mayo Clinic and Mayo College of Medicine, 51 Cancer Inflammation Program, Center for Cancer Research, National Cancer Institute and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, pp.52-53

G. Pascale, Medical Oncology and Innovative Therapies Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, p.54

F. Melanoma and O. , 55 Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute

G. Locker, S. Hamilton, J. Harris, J. Jessup, N. Kemeny et al., ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer, Journal of Clinical Oncology, vol.24, issue.33, pp.5313-5327, 2006.
DOI : 10.1200/JCO.2006.08.2644

L. Sobin and C. Wittekind, TNM classification of malignant tumors, 2002.

J. Weitz, M. Koch, J. Debus, T. Hohler, P. Galle et al., Colorectal cancer, The Lancet, vol.365, issue.9454, pp.153-165, 2005.
DOI : 10.1016/S0140-6736(05)17706-X

I. Nagtegaal, P. Quirke, and H. Schmoll, Has the new TNM classification for colorectal cancer improved care?, Nature Reviews Clinical Oncology, vol.29, issue.2, pp.119-123, 2011.
DOI : 10.1038/nrclinonc.2011.157

B. Mlecnik, G. Bindea, F. Pages, and J. Galon, Tumor immunosurveillance in human cancers, Cancer and Metastasis Reviews, vol.9, issue.1, pp.5-12, 2011.
DOI : 10.1007/s10555-011-9270-7

G. Bindea, B. Mlecnik, W. Fridman, F. Pages, and J. Galon, Natural immunity to cancer in humans, Current Opinion in Immunology, vol.22, issue.2, pp.215-222, 2010.
DOI : 10.1016/j.coi.2010.02.006

O. Finn, Cancer Immunology, New England Journal of Medicine, vol.358, issue.25, pp.2704-2715, 2008.
DOI : 10.1056/NEJMra072739

T. Gajewski, J. Louahed, and V. Brichard, Gene Signature in Melanoma Associated With Clinical Activity, The Cancer Journal, vol.16, issue.4, pp.399-403, 2010.
DOI : 10.1097/PPO.0b013e3181eacbd8

J. Galon, A. Costes, F. Sanchez-cabo, A. Kirilovsky, B. Mlecnik et al., Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, pp.1960-1964, 2006.
DOI : 10.1126/science.1129139

E. Wang, L. Miller, G. Ohnmacht, S. Mocellin, A. Perez-diez et al., Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness, Cancer Res, vol.62, pp.3581-3586, 2002.

J. Galon and W. Fridman, The Adaptive Immunologic Microenvironment in Colorectal Cancer: A Novel Perspective, Cancer Research, vol.67, issue.5, pp.1883-1886, 2007.
DOI : 10.1158/0008-5472.CAN-06-4806

W. Fridman, F. Pages, C. Sautes-fridman, and J. Galon, The immune contexture in human tumours: impact on clinical outcome, Nature Reviews Cancer, vol.29, issue.4, pp.298-306, 2012.
DOI : 10.1038/nrc3245

B. Mlecnik, M. Tosolini, A. Kirilovsky, A. Berger, G. Bindea et al., Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction, Journal of Clinical Oncology, vol.29, issue.6, pp.610-618, 2011.
DOI : 10.1200/JCO.2010.30.5425

F. Pages, A. Kirilovsky, B. Mlecnik, M. Asslaber, M. Tosolini et al., In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.35, pp.5944-5951, 2009.
DOI : 10.1200/JCO.2008.19.6147

P. Febbo, M. Ladanyi, K. Aldape, D. Marzo, A. Hammond et al., NCCN Task Force report: evaluating the clinical utility of tumor markers in oncology, J Natl Compr Canc Netw, vol.2011, issue.9, pp.1-32

S. Ogino, J. Galon, C. Fuchs, and G. Dranoff, Cancer immunology???analysis of host and tumor factors for personalized medicine, Nature Reviews Clinical Oncology, vol.25, issue.12, pp.711-719, 2011.
DOI : 10.1038/nrclinonc.2011.122

S. Ogino, A. Chan, C. Fuchs, and E. Giovannucci, Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field, Gut, vol.60, issue.3, pp.397-411, 2011.
DOI : 10.1136/gut.2010.217182

S. Ogino and M. Stampfer, Lifestyle Factors and Microsatellite Instability in Colorectal Cancer: The Evolving Field of Molecular Pathological Epidemiology, JNCI Journal of the National Cancer Institute, vol.102, issue.6, pp.365-367, 2010.
DOI : 10.1093/jnci/djq031

F. Pages, A. Berger, M. Camus, F. Sanchez-cabo, A. Costes et al., Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer, New England Journal of Medicine, vol.353, issue.25, pp.2654-2666, 2005.
DOI : 10.1056/NEJMoa051424

L. Butterfield, M. Disis, B. Fox, P. Lee, S. Khleif et al., A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers", Journal of Translational Medicine, vol.6, issue.1, p.81, 2008.
DOI : 10.1186/1479-5876-6-81

L. Butterfield, A. Palucka, C. Britten, M. Dhodapkar, L. Hakansson et al., Recommendations from the iSBTc-SITC/FDA, Immunotherapy Biomarkers. Clin Cancer Res, vol.17, pp.3064-3076, 2011.

H. Tahara, M. Sato, M. Thurin, E. Wang, L. Butterfield et al., Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology, Journal of Translational Medicine, vol.7, issue.1, p.45, 2009.
DOI : 10.1186/1479-5876-7-45

URL : https://hal.archives-ouvertes.fr/inserm-00585733

F. Pages, J. Galon, M. Dieu-nosjean, E. Tartour, C. Sautes-fridman et al., Immune infiltration in human tumors: a prognostic factor that should not be ignored, Oncogene, vol.173, issue.8, pp.1093-1102, 2010.
DOI : 10.1038/nrc1586

K. Nosho, Y. Baba, N. Tanaka, K. Shima, M. Hayashi et al., Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review, The Journal of Pathology, vol.138, issue.4, pp.350-366, 2010.
DOI : 10.1002/path.2774

S. Ogino, K. Nosho, N. Irahara, J. Meyerhardt, Y. Baba et al., Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype, Clinical Cancer Research, vol.15, issue.20, pp.6412-6420, 2009.
DOI : 10.1158/1078-0432.CCR-09-1438

E. Broussard and M. Disis, TNM Staging in Colorectal Cancer: T Is for T Cell and M Is for Memory, Journal of Clinical Oncology, vol.29, issue.6, pp.601-603, 2011.
DOI : 10.1200/JCO.2010.32.9078

F. Sallusto, J. Geginat, and A. Lanzavecchia, : Function, Generation, and Maintenance, Annual Review of Immunology, vol.22, issue.1, pp.745-763, 2004.
DOI : 10.1146/annurev.immunol.22.012703.104702

M. Ascierto, D. Giorgi, V. Liu, Q. Bedognetti, D. Spivey et al., An immunologic portrait of cancer, Journal of Translational Medicine, vol.9, issue.1, p.146, 2011.
DOI : 10.1158/1078-0432.CCR-08-3323

B. Fox, D. Schendel, L. Butterfield, S. Aamdal, J. Allison et al., Defining the critical hurdles in cancer immunotherapy, Journal of Translational Medicine, vol.9, issue.1, p.214, 2011.
DOI : 10.1126/science.317.5840.966

URL : https://hal.archives-ouvertes.fr/inserm-00691923

S. Van-der-burg, M. Kalos, C. Gouttefangeas, S. Janetzki, C. Ottensmeier et al., Harmonization of Immune Biomarker Assays for Clinical Studies, Science Translational Medicine, vol.3, issue.108, pp.108-144, 2011.
DOI : 10.1126/scitranslmed.3002785

C. Desmedt, B. Haibe-kains, P. Wirapati, M. Buyse, D. Larsimont et al., Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes, Clinical Cancer Research, vol.14, issue.16, pp.5158-5165, 2008.
DOI : 10.1158/1078-0432.CCR-07-4756

T. Iwamoto, G. Bianchini, D. Booser, Y. Qi, C. Coutant et al., Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer, JNCI Journal of the National Cancer Institute, vol.103, issue.3, pp.264-272, 2011.
DOI : 10.1093/jnci/djq524

C. Sotiriou and L. Pusztai, Gene-Expression Signatures in Breast Cancer, New England Journal of Medicine, vol.360, issue.8, pp.790-800, 2009.
DOI : 10.1056/NEJMra0801289

F. Andre, N. Berrada, and C. Desmedt, Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients, Current Opinion in Oncology, vol.22, issue.6, pp.547-551, 2010.
DOI : 10.1097/CCO.0b013e32833fb384

C. Denkert, S. Loibl, A. Noske, M. Roller, B. Muller et al., Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer, Journal of Clinical Oncology, vol.28, issue.1, pp.105-113, 2010.
DOI : 10.1200/JCO.2009.23.7370

N. Halama, S. Michel, M. Kloor, I. Zoernig, A. Benner et al., Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy, Cancer Research, vol.71, issue.17, pp.5670-5677, 2011.
DOI : 10.1158/0008-5472.CAN-11-0268

G. Erdag, J. Schaefer, M. Smolkin, D. Deacon, S. Shea et al., Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma, Cancer Research, vol.72, issue.5, pp.1070-1080, 2012.
DOI : 10.1158/0008-5472.CAN-11-3218

P. Ascierto, D. Maio, E. Bertuzzi, S. Palmieri, G. Halaban et al., Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7 th2010", Journal of Translational Medicine, vol.9, issue.1, p.32, 2010.
DOI : 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5

URL : https://hal.archives-ouvertes.fr/inserm-00834025

J. Galon, F. Pages, F. Marincola, M. Thurin, G. Trinchieri et al., The immune score as a new possible approach for the classification of cancer, Journal of Translational Medicine, vol.10, issue.1, 2012.
DOI : 10.1186/1479-5876-9-32

URL : https://hal.archives-ouvertes.fr/inserm-00664981